Oxidative stress as a possible mode of action for arsenic carcinogenesis

Toxicology Letters

Volumn 137, Issue 1-2, 2003, Pages 3-13

  Kitchin, Kirk T ^a   Ahmad, Sarfaraz ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Carcinogenesis; Dimethylarsinic acid; Iron; Monomethylarsonic acid; Oxidative stress; Reactive oxygen species

Indexed keywords

ARSENIC; ASCORBIC ACID; CACODYLIC ACID; FERRITIN; IRON; METHANEARSONIC ACID; REACTIVE OXYGEN METABOLITE;

CARCINOGENESIS; CHROMOSOME ABERRATION; CONFERENCE PAPER; DNA DAMAGE; DNA METHYLATION; HUMAN; IRON KINETICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SECRETION;

ANIMALS; ARSENIC; CACODYLIC ACID; CARCINOGENS; DNA DAMAGE; FREE RADICALS; HUMANS; METHYLATION; MICE; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES;

EID: 12244274337     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00376-4     Document Type: Conference Paper

References (42)

1. Ahmad S., Anderson W.L., Kitchin K.T. Dimethylarsinic acid effects on six biochemical parameters in B6C3F1 mice. Cancer Lett. 139:1999;129-135.
2. Ahmad S., Kitchin K.T., Cullen W.R. Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382:2000;195-202.
3. Ahmad S., Kitchin K.T., Cullen W.R. Plasmid DNA damage caused by methylated arsenicals ascorbic acid and human liver ferritin. Toxicol. Lett. 133:2002;47-57.
4. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., Ma M., Yip Li., Zakharyan R.A., Maiorino R.M., Dart R.C., Tircus M.G., Gonzalez-Ramirez D., Morgan D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13:2000;693-697.
5. Aposhian H.V., Zheng B., Aposhian M.M., Le X.C., Cebrian M.E., Cullen W., Zakharyan R.A., Ma M., Dart R.C., Cheng Z., Andrewes P., Yip Li., O'Malley G.F., Maiorino R.M., Van Voorhies W., Healy S.M., Titcomb A. DMPS-arsenic challenge test II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol. Appl. Pharmacol. 165:2000;74-83.
6. Brown J.L., Kitchin K.T. Arsenite, but not cadmium, induces ornthine decarboxylase and heme oxygenase activity in rat liver: relevance to arsenic carcinogenesis. Cancer Lett. 98:1996;227-231.
7. Brown J.L., Kitchin K.T., George M. Dimethylarsinic acid treatment alters six different rat biochemical parameters: relevance to arsenic carcinogenesis. Teratog. Carcinog. Mutag. 17:1997;71-84.
8. Cai C.X., Birk D.E., Linsenmayer T.F. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Molec. Biol. Cell. 9:1998;1037-1051.
9. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in as arseniasis-endemic area in Northeastern Taiwan. Am. J. Epidemiol. 153:2001;411-418.
10. Del Razo L.M., Styblo M., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices 2001. Toxicol. Appl. Pharmacol. 174:2000;282-293.
11. Gurr J., Liu F., Lynn S., Jan K. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat. Res. 416:1998;137-148.
12. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. 95:1998;8103-8107.
13. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172:2001;249-261.
14. Kitchin K.T., Del Razo L.M., Brown J.L., Anderson W.L., Kenyon E.M., Thomas D.J. An integrated pharmacokinetic and pharmacodynamic model of arsenite action. 1. Heme oxygenase induction in rats. Teratogenesis, Carcinogenesis Mutagenesis. 19:1999;385-402.
15. Kohn K.W., Ewig R.A.G., Erickson L.C., Zwelling L.A. Measurement of strand breaks and cross-links by alkaline elution. Hanawalt P.C., Friedberg E.C. DNA Repair, A Laboratory Manual of Research Procedures. 1981;379-401 Marcel-Dekker, New York.
16. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intemediates in human urine. Analyt. Chem. 72:2000;5172-5177.
17. Life Sciences Research Israel, Ltd. 1989. Cacodylic Acid: Combined Chronic Feeding and Oncogenicity Study in the Rat. Study No. PAL/010/CAC. [MRID 418621-01, HED Doc. No[s]. 009391, 010550].
18. Lin S., Cullen W.R., Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12:1999;924-930.
19. Lin, S., Shi, Q., Nix, F.B., Styblo, M., Beck, M.A., Herbin-Davis, K.M., Hall, L.L., Simeonsson, J.B., Thomas, D.J. 2002. A novel S-adenosy-L-methionine: Arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem.
20. Liu S.X., Athar M., Lippai I., Waldren C., Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. 98:2001;1643-1648.
21. Liu J., Kadiiska M., Liu Y., Qu W., Mason R.P., Waalkes M.P. Acute arsenic-induced free radical production and oxidative stress-related gene expression in mice. Toxicologist. 54:2000;280-281.
22. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Tox. 14:2001;371-378.
23. Mao Y., Zang L., Shi X. Singlet oxygen generation in the superoxide reaction. Biochem. Mol. Biol. Int. 36:1995;227-232.
24. Mass, M.J., Tennant, A., Roop, B., Kundu, K., Brock, K., Kligerman, A., Demarini, D., Wang, C., Cullen, W., Thomas, D., Styblo, M. 2001. Methylated arsenic(III) species react directly with DNA and are potential proximate or ultimate genotoxic forms of arsenic. Toxicologist 60, Abstract 358.
25. Matsui M., Nishigori C., Toyokuni S., Takada J., Mitsuhiko A., Ishikawa M., Imamura S., Miyachi Y. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease. J. Invest. Dermatol. 113:1999;26-31.
26. Nishikawa T., Wanibuchi H., Oawa M., Kinoshita A., Morimura K., Hiroi T., Funae Y., Kishida H., Nakae D., Fukushima S. Promoting effects on rat hepatocarcinogenesis of monomethylarsinic acid dimethylarsinic acid and trimethylarsine oxide: evidence for a possible reactive oxygen species mechanism. Int. J. Cancer. 100:2002;136-139.
27. Nordenson I., Beckman L. Is genotoxic effect of arsenic mediated by oxygen free radicals? Human Hered. 41:1991;71-73.
28. Petrick J.S., Jagadish B., Mash E.A., Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:2001;651-656.
29. Sampayo-Reyes A., Zakharyan R.A., Healy S.H., Aposhian H.V. Monomethylarsonic acid reductase and monomethyarsonous acid in hamster tissue. Chem. Res. Toxicol. 13:2000;1181-1186.
30. Stout D.L., Becker F.F. Flourometric quantification of single-stranded DNA: a method applicable to the technique of alkaline elution. Anal. Biochem. 127:1982;302-307.
31. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10:1997;27-33.
32. Thompson K., Ye Z., Connor J.R. Ferritin is a nuclear protein that responds to cell stress and protects DNA. Toxicologist. 54:2000;417. Abstract#1964.
33. Vahter M. Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8:1994;175-182.
34. Wang T.S., Hsu T.Y., Chung C.H., Wang A.S., Bau D.T., Jan K.Y. Arsenite induces oxidative DNA adducts and DNA-protein crosslinks in mammalian cells. Free Radical Biol. Med. 31:2001;321-330.
35. Wanibuchi H., Hori T., Meenakshi V., Ichihara T., Yamamoto S., Yano Y., Otani S., Nakae D., Konishi Y., Fukushima S. Promotion of rat hepatocarcinogensesis by dimethylarsinic acid as assessed in rat in vivo models: a review. Mutat. Res. 386:1997;353-361.
36. Wei M., Wanibuchi H., Yamamoto J., Li W., Fukushima S. Urinary bladder carcinogenicity of climathylarsinic acid in male F344 rats. Carcinogenesis. 20:1999;1873-1876.
37. Yamanaka K., Okada S. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ. Health Perspect. 102:1994;37-40.
38. Yamanaka K., Hasegawa A., Sawamura R., Okada S. Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165:1989;43-50.
39. Yamanaka K., Hoshino M., Okanoto M., Sawamura R., Hasegawa A., Okada S. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Comm. 168:1990;58-64.
40. Yamamoto S., Konishi Y., Matsuda T., Murai T., Shibata M., Matsui-Yuasa I., Otani S., Kuroda K., Endo G., Fukushima S. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid) in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55:1995;1271-1275.
41. Yamanaka K., Mizoi M., Kato K., Hasegawa A., Nakano M., Okada S. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenics, promote skin tumorigenesis in mice. Biol. Pharm. Bull. Jpn. 24:2001;510-514.
42. Zakharyan R.A., Sampayo-Reyes A., Healy S.M., Tsaprailis G., Board P.G., Liebler D.C., Aposhian H.V. Human monomethylarsonic acid (MMAV) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Tox. 14:2001;1051-1057.